|
End-of-day quote
Shanghai S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 3.390 CNY | +0.30% |
|
-5.31% | -14.82% |
| Market Cap | 2.66B 398M 355M 329M 297M 560M 37.58B 567M 3.94B 1.55B 19.75B 1.49B 1.46B 62.95B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.88B 431M 384M 355M 322M 606M 40.65B 613M 4.26B 1.67B 21.37B 1.62B 1.58B 68.09B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
69.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.30% | ||
| 1 week | -5.31% | ||
| Current month | -6.87% | ||
| 1 month | -4.78% | ||
| 3 months | +1.80% | ||
| 6 months | -25.98% | ||
| Current year | -14.82% |
| 1 week | 3.3 |  | 3.59 |
| 1 month | 3.3 | | 3.84 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.30% | -5.31% | -19.67% | -38.81% | 397M | |
| -1.01% | +5.13% | +58.93% | +120.37% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +70.28% | 625B | |
| -1.48% | +0.47% | +23.08% | +96.78% | 511B | |
| +0.54% | +8.95% | +39.45% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.02% | 366B | |
| +0.30% | +6.35% | +21.84% | +49.62% | 291B | |
| -0.03% | +6.04% | +0.40% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +60.53% | 237B | |
| -1.88% | +0.02% | +23.77% | +98.00% | 194B | |
| Average | -0.59% | +5.45% | +29.88% | +58.67% | 400.83B | |
| Weighted average by Cap. | -0.63% | +6.91% | +40.78% | +81.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 326M 290M 269M 243M 458M 30.73B 463M 3.22B 1.26B 16.15B 1.22B 1.2B 51.46B | 1.86B 279M 249M 230M 208M 392M 26.33B 397M 2.76B 1.08B 13.84B 1.05B 1.02B 44.1B |
| Net income | -317M -47.51M -42.33M -39.2M -35.47M -66.83M -4.48B -67.62M -470M -184M -2.36B -178M -175M -7.51B | -330M -49.36M -43.98M -40.72M -36.85M -69.43M -4.66B -70.25M -488M -192M -2.45B -185M -181M -7.8B |
| Net Debt | 411M 61.54M 54.84M 50.77M 45.94M 86.56M 5.81B 87.59M 609M 239M 3.05B 231M 226M 9.73B | 217M 32.52M 28.98M 26.83M 24.28M 45.74M 3.07B 46.28M 322M 126M 1.61B 122M 119M 5.14B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
Oct. 31
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | CN¥3.390 | +0.30% | 11,681,200 |
| 26-10-20 | CN¥3.380 | 0.00% | 11,732,000 |
| 26-10-19 | CN¥3.380 | -2.03% | 17,583,406 |
| 26-10-16 | CN¥3.450 | -0.58% | 18,929,300 |
| 26-10-15 | CN¥3.470 | -1.42% | 15,789,300 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
